Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome

Heart and Vessels

Volumn 24, Issue 3, 2009, Pages 175-180

  Yun, Kyeong Ho ^a   Jeong, Myung Ho ^b   Oh, Seok Kyu ^a   Rhee, Sang Jae ^a   Park, Eun Mi ^a   Lee, Eun Mi ^a   Yoo, Nam Jin ^a   Kim, Nam Ho ^a   Ahn, Young Keun ^b   Jeong, Jin Won ^a  

^a Wonkwang University Hospital   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

C reactive protein; Inflammation; Percutaneous coronary angioplasty; Stent

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; CHOLESTEROL; CLOPIDOGREL; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PACLITAXEL; RAPAMYCIN; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 66149084839     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1110-5     Document Type: Article

References (27)

1. Lind L (2003) Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169:203-214
2. Chew DP, Bhatt DL, Robbins MA, Penn MS, Schneider JP, Lauer MS, Topol EJ, Ellis SG (2001) Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 104:992-997
3. Dibra A, Mehilli J, Braun S, Hadamitzky M, Baum H, Dirschinger J, Schühlen H, Schömig A, Kastrati A (2003) Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 114:715-722
4. Buffon A, Liuzzo G, Biasucci LM, Pasqualetti P, Ramazzotti V, Rebuzzi AG, Crea F, Maseri A (1999) Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 34:1512-1521
5. Magadle R, Hertz I, Merlon H, Weiner P, Mohammedi I, Robert D (2004) The relationship between preprocedural C-reactive protein levels and early and late complications in patients with acute myocardial infarction undergoing interventional coronary angioplasty. Clin Cardiol 27:163-168
6. Azar R, McKay R, Kiernan F, Seecharran B, Feng YJ, Fram DB, Wu AH, Waters DD (1997) Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol 80:1476-1478
7. Almagor M, Keren A, Banai S (2003) Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. Am Heart J 145:248-253
8. Saleh N, Svane B, Hansson L, Jensen J, Nilsson T, Danielsson O, Tornvall P (2005) Response of serum C-reactive protein to percutaneous coronary intervention has prognostic value. Clin Chem 51:2124-2130
9. Gach O, Legrand V, Biessaux Y, Chapelle JP, Vanbelle S, Pierard LA (2007) Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris. Am J Cardiol 99:31-35
10. Ridker PM, Hennekens CH, Buring JE, Rifai N (2002) C reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843
11. Mendall MA, Strachan DP, Butland BK, Ballam L, Morris J, Sweetnam PM, Elwood PC (2000) C-reactive protein: Relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J 21:1584-1590
12. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E (1998) C-reactive protein is a potent predictor of mortality independently and in combination with troponin T in acute coronary syndromes. J Am Coll Cardiol 31: 1460-1465
13. Yeh ET (2005) High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease. Clin Cardiol 28:408-412
14. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349:462-466
15. Lenderink T, Boersma E, Heeschen C, Vahanian A, de Boer MJ, Umans V, van den Brand MJ, Hamm CW, Simoons ML; CAPTURE Investigators (2003) Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA. Eur Heart J 24:77-85
16. Veselka J, Prochazkova S, Duchonova R, Bolomova I, Urbanova T, Tesar D, Honek T (2002) Relationship of C-reactive to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coron Artery Dis 13:151-154
17. Veselka J, Prochazkova S, Duchonova R, Homolova I, Tesar D (2005) Relationship of C-reactive protein to adverse cardiovascular events in patients treated by percutaneous coronary intervention for stable angina pectoris. Int Heart J 46:195-204
18. Chan AW, Bhatt DL, Chew DP, Quinn MJ, Moliterno DJ, Topol EJ, Ellis SG (2002) Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation 105:691-696
19. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA (2000) Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol 85:92-95
20. Sanchez-Margalet V, Cubero JM, Martin-Romero C, Cubero J, Cruz-Fernandez JM. Goberna R (2002) Inflammatory response to coronary stent implantation in patients with unstable angina. Clin Chem Lab Med 40:769-774
21. Bonz AW, Lengenfelder B, Jacobs M, Strotmann J, Held S, Ertl G, Voelker W (2003) Cytokine response after percutaneous coronary intervention in stable angina: Effect of selective glycoprotein IIb/IIIa receptor antagonism. Am Heart J 145:693-699
22. Gaspardone A, Crea F, Versaci F, Tomai F, Pellegrino A, Chiariello L, Gioffre PA (1998) Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 82:515-518
23. Cusack MR, Marber MS, Lambiase PD, Bucknall CA, Redwood SR (2002) Systemic inflammation in unstable angina is the results of myocardial necrosis. J Am Coll Cardiol 39:1917-1923
24. Merlini PA, Cugno M, Rossi ML, Agricola P, Repetto A, Fetiveau R, Diotallevi P, Canosi U, Mannucci PM, Ardissino D (2004) Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction. Am J Cardiol 93:822-825
25. Brunetti ND, Troccoli R, Correale M, Pellegrino PL, Biase MD (2006) C-reactive protein in patients with acute coronary syndrome: Correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int J Cardiol 109:248-256
26. Kazmierczak E, Sobieska M, Kazmierczak M, Mrozikiewicz A, Wiktorowicz K (1999) Intense acute phase response in ischemic patients. Int J Cardiol 68:69-73
27. Ozer N, Tangurek B, Firat F, Ozer S, Tartan Z, Ozturk R, Ozay B, Ciloglu F, Yilmaz H, Cam N (2008) Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Heart Vessels 23:75-82